Article Correctness Is Author's Responsibility: Patients taking nivolumab experience five-fold increase in overall survival compared to chemotherapy

Pooled data on two clinical trials demonstrate patients taking nivolumab realized a greater than five-fold increase in five-year overall survival rate compared with the chemotherapy docetaxel.